Omission of doxorubicin from the treatment of stage II–III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial
Titel:
Omission of doxorubicin from the treatment of stage II–III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial
Auteur:
Pritchard-Jones, Kathy Bergeron, Christophe de Camargo, Beatriz van den Heuvel-Eibrink, Marry M Acha, Tomas Godzinski, Jan Oldenburger, Foppe Boccon-Gibod, Liliane Leuschner, Ivo Vujanic, Gordan Sandstedt, Bengt de Kraker, Jan van Tinteren, Harm Graf, Norbert
Verschenen in:
Lancet
Paginering:
Jaargang 386 (2015) nr. 9999 pagina's 9 p.
Jaar:
2015
Inhoud:
Uitgever:
Pritchard-Jones et al. Open Access article distributed under the terms of CC BY